Unichem-Labs. Stock/Share Prices, Buy and Sell Unichem-Labs. NSE Stocks

Unichem Laboratories Ltd NSE / BSE
Pharmaceuticals, Mid Cap

Invest

21 Aug 2017 | 04:15 PM

244.80

-4.00 (-1.61%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-9.67%

Return (1Y)

Underperformed Nifty 500 by 25.23%
More Volatile

1.73%

Standard Deviation (1Y)

Higher than Nifty 500 by 0.97%
Not so consistent

4/12

Months

underperformed Nifty 500
AxisDirect View

No View

52 Week High-Low

328

233

News & Announcements

Unichem Laboratories standalone net profit declines 94.18% in the June 2017 quarter
12 days ago

Unichem Laboratories standalone net profit declines 94.18% in the June 2017 quarter

09 - Aug - 2017 12:00 AM | 12 days ago

Net profit of Unichem Laboratories declined 94.18% to Rs 1.50 crore in the quarter ended June 2017 as against Rs 25.77 crore during the previous quarter ended June 2016. Sales declined 8.10% to Rs 310.10 crore in the quarter ended June 2017 as against Rs 337.43 crore during the previous quarter ended June 2016.
Particulars Quarter Ended
Jun. 2017 Jun. 2016 % Var.
Sales 310.10 337.43 -8
OPM % -0.07 13.11 -
PBDT 7.31 48.69 -85
PBT -3.05 38.93 PL
NP 1.50 25.77 -94
Powered by Capital Market - Live News
Unichem Laboratories to conduct board meeting
27 days ago

Unichem Laboratories to conduct board meeting

25 - Jul - 2017 12:00 AM | 27 days ago

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 9 August 2017, to interalia consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2017.
Powered by Capital Market - Live News
Unichem Laboratories receives ANDA approval for Losartan Potassium and Hydrochlorothiazide Tablets
27 days ago

Unichem Laboratories receives ANDA approval for Losartan Potassium and Hydrochlorothiazide Tablets

25 - Jul - 2017 12:00 AM | 27 days ago

Unichem Laboratories has received ANDA approval from United States Food and Drug Administration for Losartan Potassium and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg , 100 mg/12.5 mg and 100 mg/25 mg which are therapeutically equivalent to Hyzaar Tablets 50 mg/12.5 mg , 100 mg/12.5 mg and 100 mg/25 mg of Merck Sharp & Dohme Corporation.
Powered by Capital Market - Live News
Unichem Laboratories receives EIR for its Goa formulations manufacturing facility
52 days ago

Unichem Laboratories receives EIR for its Goa formulations manufacturing facility

30 - Jun - 2017 12:00 AM | 52 days ago

Unichem Laboratories announced that the Company's formulations manufacturing facility at Goa has received an Establishment Inspection Report from the USFDA. This receipt indicates the successful closure of the inspection and the queries during the audit (Form 483). The inspection has now been closed by the USFDA. The inspection was carried out between 14 March 2017 and 20 March 2017.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Unichem Laboratories Ltd is trading very close to its 52 Week Low
FII shareholding in Unichem Laboratories Ltd has increased by 8.58% since past 3 Months
MF shareholding in Unichem Laboratories Ltd has decreased by -7.8% since past 3 Months
FII shareholding in Unichem Laboratories Ltd has increased by 29.4% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Jun. 2017	Jun. 2016	% Var.
Sales	310.10	337.43	-8
OPM %	-0.07	13.11	-
PBDT	7.31	48.69	-85
PBT	-3.05	38.93	PL
NP	1.50	25.77	-94

Unichem Laboratories Ltd NSE / BSE Pharmaceuticals, Mid Cap

244.80 -4.00 (-1.61%)

News & Announcements

Price vs Volume

Stock Trivia

Unichem Laboratories Ltd NSE / BSE
Pharmaceuticals, Mid Cap

244.80

-4.00 (-1.61%)